Accessibility Menu

Getinge Ab (publ)(FRA) GTN

Market Cap€5.91BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€21.68
+0.74%
+0.16Today

Getinge Ab (publ) Financials at a Glance

Market Cap

€5.91BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€3.14K

Net Income (TTM)

€245.80

EPS (TTM)

€0.90

P/E Ratio

24.14

Dividend

€0.44

Beta (Volatility)

-0.10 (Low)

Price

€21.68

Volume

0

Open

€21.68

Previous Close

€21.52

Daily Range

€21.68 - €21.68

52-Week Range

€16.36 - €21.85

Estimated Earnings Date

N/A

GTN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Getinge Ab (publ)

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11,758

CEO

Mattias Sven Perjos

Website

www.getinge.com

GTN Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

9.12%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.14%

Dividend Yield

2.03%

Payout Ratio

N/A

Stock Overview

Market Cap

€5.91BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

272.37M

Volume

0

Avg. Volume

49.591

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Getinge Ab (publ) Performance Analysis

Getinge Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 2,660,085,575-0.2%
20232023-12-31EUR 2,773,096,2994.2%
20242024-12-31EUR 3,039,323,8439.6%
20252025-12-31EUR 3,159,315,0803.9%
Getinge Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.86-20.0%
20232023-12-31EUR 0.77-10.3%
20242024-12-31EUR 0.53-31.8%
20252025-12-31EUR 0.7542.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€769.74

+1.0%

Gross Profit

€379.86

+1.1%

Gross Margin

49.35%

+1.1%

Market Cap

€5.91BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.41

+1.1%

Employees

11,758

+1.0%

Net Income

€77.06

+1.6%

EBITDA

€170.46

+1.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.19K

+1.4%

Total Debt

€1.00K

+1.0%

Accounts Receivable

€459.74

+1.1%

Inventory

€618.16

+1.0%

Long Term Debt

€821.42

+1.0%

Short Term Debt

€181.74

+0.9%

Return on Assets

4.79%

+1.8%

Return on Invested Capital

6.90%

+0.9%

Free Cash Flow

€90.08

+1.9%

Operating Cash Flow

€116.82

+1.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,701.85-0.01%
^DJIDJI
$53,396.81-0.00%
^IXICNASDAQ
$26,314.93-0.01%
BTCBitcoin
$64,721.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
MRNAModerna
$140.50+1.23%
IBITiShares Bitcoin Trust
$38.79+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$9.26+0.06%
INTCIntel
$93.22-0.04%

Questions About GTN

What is the current price of Getinge Ab (publ)?

Getinge Ab (publ) is trading at €21.68 per share.

What is the 52-week range for Getinge Ab (publ)?

Over the past 52 weeks, Getinge Ab (publ) has traded between €16.36 and €21.85.

How much debt does Getinge Ab (publ) have?

As of the most recent reporting period, Getinge Ab (publ) reported total debt of €1.00B.

How much cash does Getinge Ab (publ) have on hand?

Getinge Ab (publ) reported €185.45M in cash and cash equivalents in its most recent financial results.

What is Getinge Ab (publ)’s dividend yield?

Getinge Ab (publ) currently has a dividend yield of 2.03%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services